GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadmon Holdings Inc (NAS:KDMN) » Definitions » Price-to-Tangible-Book

Kadmon Holdings (Kadmon Holdings) Price-to-Tangible-Book : (As of Apr. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kadmon Holdings Price-to-Tangible-Book?

As of today (2024-04-25), Kadmon Holdings's share price is $9.50. Kadmon Holdings's Tangible Book per Share of Sep. 2021 for the quarter that ended in Sep. 2021 was $-0.21. Hence, Kadmon Holdings's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Kadmon Holdings's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Kadmon Holdings's highest Price to Tangible Book Ratio was 63.77. The lowest was 0.00. And the median was 6.60.

KDMN's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Kadmon Holdings's share price is $9.50. Kadmon Holdings's Book Value per Sharefor the quarter that ended in Sep. 2021 was $-0.19. Hence, Kadmon Holdings's P/B Ratio of today is .


Kadmon Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Kadmon Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadmon Holdings Price-to-Tangible-Book Chart

Kadmon Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Tangible-Book
Get a 7-Day Free Trial - - 5.52 6.05 10.48

Kadmon Holdings Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.15 10.48 63.77 - -

Competitive Comparison of Kadmon Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Kadmon Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kadmon Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadmon Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kadmon Holdings's Price-to-Tangible-Book falls into.



Kadmon Holdings Price-to-Tangible-Book Calculation

Kadmon Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2021 )
=9.50/-0.206
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Kadmon Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kadmon Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadmon Holdings (Kadmon Holdings) Business Description

Traded in Other Exchanges
N/A
Address
450 East 29th Street, New York, NY, USA, 10016
Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.
Executives
Harlan Waksal director, officer: President, CEO WAKSAL CONSULTING LLC, 7 NORTH WILLOW STREET, SUITE 6, MONTCLAIR NJ 07042
Nancy Miller-rich director C/O INTERCEPT PHARMACEUTICALS, INC., 10 HUDSON YARDS, 37TH FL, NEW YORK NY 10001
Cynthia Schwalm director C/O G1 THERAPEUTICS, 700 PARK OFFICES DR, SUITE 200, P.O. BOX 110341, RESEARCH TRIANGLE PARK NC 27709
Arthur S Kirsch director 7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4
David E Cohen director 3160 PORTER DRIVE, PALO ALTO CA 94304
Eugene Bauer director C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016
Tasos Konidaris director 103 JFK PARKWAY, SHORT HILLS NJ 07078
John L Ryan officer: Executive Vice President, CMO C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Steven Meehan officer: EVP, Chief Financial Officer 450 E. 29TH STREET NEW YORK NY 10016
Kyle Carver officer: Principal Accounting Officer, Controller 450 EAST 29TH STREET NEW YORK NY 10016
Gregory S. Moss officer: EVP, General Counsel, Chief Compliance Officer 450 EAST 29TH STREET, 16TH FLOOR, NEW YORK NY 10016
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc other: Former 10% owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Steven N. Gordon officer: Exec VP, GC, Chief Admin, Comp C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016

Kadmon Holdings (Kadmon Holdings) Headlines

From GuruFocus